Bank of America
ACAD icon

Bank of America’s Acadia Pharmaceuticals ACAD Stock Holding History

Bank of America’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,700
Closed -$27.6K – 8144
2024
Q2 		$27.6K Buy
1,700
+1,000
+143% +$16.1K ﹤0.01% 6665
2024
Q1 		$12.9K Buy
+700
New +$17.3K ﹤0.01% 6832
2023
Q1 		– Sell
-30,000
Closed -$478K – 7752
2022
Q4 		$478K Buy
+30,000
New +$469K ﹤0.01% 5415
2019
Q4 		– Sell
-46,800
Closed -$1.68M – 7034
2019
Q3 		$1.68M Buy
+46,800
New +$1.42M ﹤0.01% 4190
2019
Q1 		– Sell
-50,000
Closed -$809K – 7057
2018
Q4 		$809K Hold
50,000
– – ﹤0.01% 4577
2018
Q3 		$1.04M Hold
50,000
– – ﹤0.01% 4458
2018
Q2 		$764K Buy
+50,000
New +$892K ﹤0.01% 4651
2016
Q1 		– Sell
-2,700
Closed -$96K – 6948
2015
Q4 		$96K Hold
2,700
– – ﹤0.01% 5743
2015
Q3 		$89K Hold
2,700
– – ﹤0.01% 5712
2015
Q2 		$113K Hold
2,700
– – ﹤0.01% 5532
2015
Q1 		$88K Sell
2,700
-21,000
-89% -$722K ﹤0.01% 5376
2014
Q4 		$752K Sell
23,700
-4,400
-16% -$125K ﹤0.01% 4278
2014
Q3 		$696K Sell
28,100
-8,200
-23% -$192K ﹤0.01% 4302
2014
Q2 		$820K Sell
36,300
-3,800
-9% -$79.3K ﹤0.01% 4153
2014
Q1 		$976K Buy
40,100
+10,900
+37% +$276K ﹤0.01% 3923
2013
Q4 		$730K Sell
29,200
-11,600
-28% -$274K ﹤0.01% 4399
2013
Q3 		$1.12M Buy
40,800
+10,100
+33% +$211K ﹤0.01% 3838
2013
Q2 		$557K Buy
+30,700
New +$423K ﹤0.01% 4654

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Bank of America's ACAD Position: Q1 2026 in Review

Bank of America increased its Acadia Pharmaceuticals (ACAD) stake by 27% in Q1 2026, buying an estimated $7.94M and bringing the position to 1,553,770 shares worth $34.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1913.

Bank of America first reported a position in ACAD in Q2 2013 and has held it in 52 quarters since. 342 funds tracked by Wall St. Rank hold ACAD as of Q1 2026.

  • Bank of America held 1,553,770 shares of Acadia Pharmaceuticals worth $34.6M as of Q1 2026.
  • Bank of America bought 332,325 Acadia Pharmaceuticals shares in Q1 2026, an estimated $7.94M.
  • Acadia Pharmaceuticals made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #1913 holding.
  • Bank of America first reported a position in Acadia Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • 342 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.